Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kim James Charney"'
Autor:
Jane L. Messina, Dale Han, Richard L. White, Jonathan S. Zager, Nicola Mozzillo, Stanley P. L. Leong, Mohammed Kashani-Sabet, Schlomo Schneebaum, Daniel C. Thomas, John T. Vetto, Kim James Charney, Vernon K. Sondak, Gang Han, Barbara A. Pockaj, Mark B. Faries
Publikováno v:
Annals of Surgical Oncology. 26:2254-2262
Factors that predict melanoma recurrence after a negative sentinel lymph node biopsy (SLNB) are not well-defined. We evaluated melanoma recurrence patterns, factors prognostic for recurrence, and the impact of recurrence on outcomes after a negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52559398e49f1618bb9fe31e2a7fe3f
https://doi.org/10.1245/s10434-019-07369-w
https://doi.org/10.1245/s10434-019-07369-w
Autor:
Jonathan S. Zager, Vernon K. Sondak, Nicola Mozzillo, Stanley P. L. Leong, Barbara A. Pockaj, Kim James Charney, Mohammed Kashani-Sabet, Richard L. White, Gang Han, John T. Vetto, Nicholas D. Klemen, Schlomo Schneebaum, Harald J. Hoekstra, Dale Han, Jane L. Messina
Publikováno v:
Journal of surgical oncology. 119(8)
BACKGROUND Completion lymph node dissection (CLND) for sentinel lymph node (SLN) disease in melanoma patients is debated. We evaluated the impact of CLND on survival and assessed for predictors of nonsentinel node metastasis (positive CLND). METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079d44de6e7a55721ba0eedde2f0671b
https://pubmed.ncbi.nlm.nih.gov/30883771
https://pubmed.ncbi.nlm.nih.gov/30883771
Autor:
Seng-Jaw Soong, Richard Essner, Jeffrey E. Gershenwald, Merrick I. Ross, Stanley P. L. Leong, Harald J. Hoekstra, Eli Avisar, David Chu, Shouluan Ding, Eric D. Whitman, Mohammed Kashani-Sabet, Daniel L Debonis, Axel Hauschild, John T. Vetto, Gregory D. Ayers, Harold J. Wanebo, Mark B. Faries, Kim James Charney, Barbara A. Pockaj, Bruce J. Averbook, Yu Shyr, Michael P. Vezeridis, Richard L. White, Virginia H. Stell, Friederike Egberts, Vijay Trisal, Zhiguo Zhao, Carlos A. Garberoglio, Aaron H. Chevinsky, Lynne D. Berry, Jonathan C. Salo
Publikováno v:
Annals of Surgical Oncology, 18(13), 3593-3600. SPRINGER
Numerous predictive factors for cutaneous melanoma metastases to sentinel lymph nodes have been identified; however, few have been found to be reproducibly significant. This study investigated the significance of factors for predicting regional nodal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278d3720e4032f99ed5346c3c9b2b925
https://doi.org/10.1245/s10434-011-1826-9
https://doi.org/10.1245/s10434-011-1826-9
Autor:
Richard L. White, Barbara A. Pockaj, Eli Avisar, Jaimie L. Weber, Mia Djulbegovic, Suroosh S. Marzban, Lynne D. Berry, Heidi Chen, Yu Shyr, Stanley P. L. Leong, Kim James Charney, Vernon K. Sondak, Jonathan S. Zager, Nicola Mozzillo, John T. Vetto, Dale Han, Robert S. Krouse, Mohammed Kashani-Sabet, Sanjana Iyengar, Jane L. Messina
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(35)
Purpose Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are continually evolving. We present a large multi-institutional study to determine factors predictive of sentinel lymph node (SLN) metastasis in thin melanoma. Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fea0594b60b55e209694078badefa3
https://pubmed.ncbi.nlm.nih.gov/24190111
https://pubmed.ncbi.nlm.nih.gov/24190111
Autor:
John T. Vetto, Jeffrey E. Gershenwald, Kim James Charney, Richard L. White, Neil A. Accortt, Barbara A. Pockaj, Eli Avisar, Merrill A. Biel, Richard Essner, David Chu, Harald J. Hoekstra, Stanley P. L. Leong, Harold J. Wanebo, Merrick I. Ross, Seng-Jaw Soong, Carlos A. Garberoglio
Publikováno v:
Archives of otolaryngology--headneck surgery. 132(4)
To determine the impact of sentinel lymph node (SLN) status and other risk factors on recurrence and overall survival in head and neck melanoma patients.The SLN Working Group, based in San Francisco, Calif, with its 11 member centers, the John Wayne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d6bf59103075a6490954ca8efdf8128
https://pubmed.ncbi.nlm.nih.gov/16618904
https://pubmed.ncbi.nlm.nih.gov/16618904
Autor:
Han D; Dale Han, Jonathan S. Zager, Sanjana Iyengar, Mia Djulbegovic, Jaimie L. Weber, Suroosh S. Marzban, Vernon K. Sondak, and Jane L. Messina, Moffitt Cancer Center, Tampa; Eli Avisar, University of Miami, Miami, FL; Yu Shyr, Heidi Chen, and Lynne D. Berry, Vanderbilt University School of Medicine, Nashville, TN; John T. Vetto, Oregon Health and Science University, Portland, OR; Richard L. White, Carolinas Medical Center, Charlotte, NC; Barbara Pockaj, Mayo Clinic, Scottsdale; Robert Krouse, Southern Arizona Veterans Administration Health Care System, Tucson, AZ; Nicola Mozzillo, Istituto Nazionale dei Tumori-Fondazione Pascale, Naples, Italy; Kim James Charney, St Joseph Hospital, Orange; and Mohammed Kashani-Sabet and Stanley P. Leong, California Pacific Medical Center and Research Institute, San Francisco, CA., Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Dec 10; Vol. 31 (35), pp. 4387-93. Date of Electronic Publication: 2013 Nov 04.